J&J COVID-19 vaccine 66% effective globally

Video Credit: Reuters Studio
Published on January 29, 2021 - Duration: 02:08s

J&J COVID-19 vaccine 66% effective globally

Johnson & Johnson announced Friday that its single-dose vaccine was 66% effective globally in preventing COVID-19, and 72% effective in the United States.

The company plans to seek emergency use authorization from the U.S. Food and Drug Administration next week.

Emma Jehle has more.


You are here


💡 newsR Knowledge: Other News Mentions


Related news from verified sources

Novavax Inc said on Thursday its coronavirus vaccine was 89.3% effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as...
on January 28, 2021 • IndiaTimes

Obesity, considered to be a big risk factor for COVID-19 may also make vaccines less effective, as many researchers believe. We explain why
on January 22, 2021 • IndiaTimes

US biotechnology firm Moderna on Monday said lab studies showed its Covid-19 vaccine would remain protective against variants of the coronavirus first identified...
on January 25, 2021 • IndiaTimes

Related videos from verified sources

Truss criticises Macron's AstraZeneca efficacy comments 00:35
Video credit: PA - Press Association STUDIO - Published on January 31, 2021 

Johnson & Jonson vaccine 66% effective 00:26
Video credit: FOX 4 Now Florida - Published on January 30, 2021 

Johnson & Johnson's COVID-19 Vaccine Still Has Advantages Despite Less Effectiveness 02:10
Video credit: CBS 11 Dallas - Published on January 30, 2021 

You might like